Seth Kiernan
SEC CIK 1890439 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | VP, Chief Commercial Off | 53.1K | — | — | 4 | 2022-02-28 | 2023-02-28 |
Most active insiders at LXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Artal Group S.A. | Dir, 10% | $2.00M | — |
| 2 | DEBBANE RAYMOND | Dir | $723.0K | — |
| 3 | Martens Rachel Yap | SVP, Partnerships, Corp Strat | — | — |
| 4 | Gopinathan Suma | SVP, Discovery | — | — |
| 5 | Artal Participations S.a r.l. | Dir, 10% | — | — |
| 6 | Cheung Ivan | Dir | — | — |
| 7 | Exton Michael | CEO, Dir | — | — |
| 8 | Sullivan Diane E. | Dir | — | — |
| 9 | McDermott Wendy | SVP, Human Resources | — | — |
| 10 | Granowitz Craig B | SVP, Chief Medical Off | — | — |
Seth Kiernan made no open-market trades at LXRX in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-01 | 2023-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Seth Kiernan | VP, Chief Commercial Off | F - Tax | $2.17 | -11.8K | 53.1K | -18% | -$25.6K |
| DM | 2023-03-01 | 2023-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Seth Kiernan | VP, Chief Commercial Off | M - OptEx | — | +43.1K | 36.7K | New | — |
| DM | 2022-02-28 | 2022-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Seth Kiernan | VP, Chief Commercial Off | M - OptEx | — | +30.1K | 24.8K | New | — |
| D | 2022-02-28 | 2022-02-28 | LXRX | LEXICON PHARMACEUTICALS, INC. | Seth Kiernan | VP, Chief Commercial Off | F - Tax | $2.85 | -8,261 | 21.9K | -27% | -$23.5K |
Purchase Sale Sale after option exercise All abbreviations